MICROBIOTA AND BLADDER CANCER

In France, bladder cancer (BC) is the fourth leading cause of cancer (14,000 new cases per year). It affects older men (\>60 years old) and smoking is the main identified risk factor (RF). The persistence of a high sex ratio despite the increase in smoking among women has led to research into other environmental RFs for BC, which may include the microbiota. Recently, the concept of urinary microbiota in asymptomatic patients has been accepted. Studies on the urinary microbiota have shown dysbiosis associated with certain urogenital pathologies. Thus, similar to certain dysbiosis of the coloni

Trial Details

NCT ID
NCT07080333
Phase
NA
Sponsor
Centre Hospitalier Universitaire de Nice
Status
RECRUITING
Cancer Type
Bladder Cancer
Interventions
  • biopsy
Locations (sample)
  • Cannes, France|43.55135,7.01275
  • Marseille, France|43.29695,5.38107
  • Menton, France|43.77649,7.50435
  • Nice, France|43.70313,7.26608
  • Nîmes, France|43.83665,4.35788

Key Eligibility Criteria

  • Age \> 18 years old
  • First RTUV for suspected CV in the presence of macroscopic haematuria or other clinical signs and/or urinary cytology and/or cystoscopy and/or imag…
  • Signed informed consent form
  • Affiliation with a social security scheme

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Bladder Cancer Trials on Trialify →